HalvorsenR.A.Jr, ThompsonW.M.CT of esophageal neoplasms. Radiol Clin North Am.1989; 27: 667–685.
2.
ChakA., CantoM., GerdesH.Prognosis of esophageal cancers preoperatively staged to be locally invasive (T4) by endoscopic ultrasound (EUS): a multicenter retrospective cohort study. Gastrointest Endosc.1995; 42: 501–506.
3.
GreenbergJ., DurkinM., Van DrunenM.Computed tomography or endoscopic ultrasonography in preoperative staging of gastric and esophageal tumors. Surgery.1994; 116: 696–701.
4.
HolscherA.H., DittlerH.J., SiewertJ.R.Staging of squamous esophageal cancer: accuracy and value. World J Surg.1994; 18: 312–320.
5.
FrancoisE., PerouxJ., MourouxJ.Preoperative endosonographic staging of cancer of the cardia. Abdom Imaging.1996; 21: 483–487.
6.
PerngD.S., JanC.M., WangW.M.Computed tomography, endoscopic ultrasonography and intraoperative assessment in TN staging of gastric carcinoma. J Formos Med Assoc.1996; 95: 378–385.
7.
HalvorsenR.A.Jr, YeeJ., McCormickV.D.Diagnosis and staging of gastric cancer. Semin Oncol.1996; 23: 325–335.
8.
ScatarigeJ.C., DiSantisD.J.CT of the stomach and duodenum. Radiol Clin North Am.1989; 27: 687–706.
9.
GolettiO., BucciantiP., ChiarugiM.Laparoscopic sonography in screening metastases from gastrointestinal cancer: comparative accuracy with traditional procedures. Surg Laparosc Endosc.1995; 5: 176–182.
10.
ThoeniR.F.CT evaluation of carcinomas of the colon and rectum. Radiol Clin North Am.1989; 27: 731–741.
11.
ZerhouniE.A., RutterC., HamiltonS.R.CT and MR imaging in the staging of colorectal carcinoma: Report of the Radiology Diagnostic Oncology Group II. Radiology.1996; 200: 443–451.
12.
HollettM.D., JeffreyR.B.Jr, Nino-MurciaM.Dual-phase helical CT of the liver: value of arterial phase scans in the detection of small (<=1.5 cm) malignant hepatic neoplasms. AJR Am J Roentgenol.1995; 164: 879–884.
13.
KarlR.C., MorseS.S., HalpertR.D.Preoperative evaluation of patients for liver resection: appropriate CT imaging. Ann Surg.1993; 217: 226–232.
14.
FantiniG.A., DeCosseJ.J.Surveillance strategies after resection of carcinoma of the colon and rectum. Surg Gynecol Obstet.1990; 171: 267–273.
15.
KelvinF.M., KorobkinM., HeastonD.K.The pelvis after surgery for rectal carcinoma: serial CT observations with emphasis on nonneoplastic features. AJR Am J Roentgenol.1983; 141: 959–964.
16.
SemelkaR.C., ShoenutJ.P., KroekerM.Focal liver disease: comparison of dynamic contrast-enhanced CT and T2-weighted fat-suppressed, FLASH, and dynamic gadolinium-enhanced MR imaging at 1.5T. Radiology.1992; 184: 687–694.
17.
MartinE.W.Jr, CareyL.C.Second-look surgery for colorectal cancer: the second time around. Ann Surg.1991; 214: 321–325.
18.
WangensteenO., LewisJ., ArhelgerS.An interim report upon the “second-look” procedure for cancer of the stomach, colon and rectum for “limited intraperitoneal carcinosis.”Surg Gynecol Obstet.1954; 99: 257–267.
19.
PosnerM.R., MayerR.J.The use of serologic tumor markers in gastrointestinal malignancies. Hematol Oncol Clin North Am.1994; 8: 533–553.
20.
MintonJ.P., HoehnJ.L., GerberD.M.Results of a 400-patient carcinoembryonic antigen second-look colorectal cancer study. Cancer.1985; 55: 1284–1290.
21.
SchneebaumS., ArnoldM.W., YoungD.Role of carcinoembryonic antigen in predicting resectability of recurrent colorectal cancer. Dis Colon Rectum.1993; 36: 810–815.
22.
MoertelC.G., FlemingT.R., MacdonaldJ.S.An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. JAMA.1993; 270: 943–947.
23.
BertschD.J., BurakW.E.Jr, YoungD.C.Radioimmunoguided surgery system improves survival for patients with recurrent colorectal cancer. Surgery.1995; 118: 634–638.
24.
O'SullivanG.C., CollinsJ.R., O'BrienF.Micrometastases in bone marrow of patients undergoing “curative” surgery for gastrointestinal cancer. Gastroenterology.1995; 109: 1535–1540.
25.
SoethE., VogelI., RoderC.Comparative analysis of bone marrow and venous blood isolates from gastrointestinal cancer patients for the detection of disseminated tumor cells using reverse transcription PCR. Cancer Res.1997; 57: 3106–3110.
26.
O'SullivanG., CollinsJ., KellyJ.Micrometastases: marker of metastatic potential or evidence of residual disease?Gut.1997; 40: 512–515.
